Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
dc.contributor.author | Moreno, Estefanía | |
dc.contributor.author | Andradas, Clara | |
dc.contributor.author | Medrano, Mireia | |
dc.contributor.author | Caffarel, María M. | |
dc.contributor.author | Blasco-Benito, Sandra | |
dc.contributor.author | Pazos, M. Ruth | |
dc.contributor.author | Irving, Andrew J. | |
dc.contributor.author | Lluís, Carme | |
dc.contributor.author | Canela, Enric I. | |
dc.contributor.author | McCormick, Peter J. | |
dc.contributor.author | Gómez Cañas, María | |
dc.contributor.author | Pérez Gómez, Eduardo | |
dc.contributor.author | Fernández Ruiz, José Javier | |
dc.contributor.author | Guzmán Pastor, Manuel | |
dc.contributor.author | Sánchez García, María Cristina | |
dc.date.accessioned | 2024-01-16T15:31:24Z | |
dc.date.available | 2024-01-16T15:31:24Z | |
dc.date.issued | 2014-08 | |
dc.description.abstract | The G protein-coupled receptors CB2 (CB2R) and GPR55 are overexpressed in cancer cells and human tumors. Because a modulation of GPR55 activity by cannabinoids has been suggested, we analyzed whether this receptor participates in cannabinoid effects on cancer cells. Here we show that CB2R and GPR55 form heteromers in cancer cells, that these structures possess unique signaling properties, and that modulation of these heteromers can modify the antitumoral activity of cannabinoids in vivo. These findings unveil the existence of previously unknown signaling platforms that help explain the complex behavior of cannabinoids and may constitute new targets for therapeutic intervention in oncology. | |
dc.description.department | Depto. de Bioquímica y Biología Molecular | |
dc.description.faculty | Fac. de Medicina | |
dc.description.refereed | TRUE | |
dc.description.status | pub | |
dc.identifier.citation | Moreno E, Andradas C, Medrano M, Caffarel MM, Pérez-Gómez E, Blasco-Benito S, Gómez-Cañas M, Pazos MR, Irving AJ, Lluís C, Canela EI,Fernández-Ruiz J, Guzmán M, McCormick PJ, Sánchez C. Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling. J Biol Chem. 2014, 289(32):21960-72. | |
dc.identifier.issn | 0021-9258 | |
dc.identifier.officialurl | https://www.sciencedirect.com/science/article/pii/S0021925820331367?via%3Dihub | |
dc.identifier.uri | https://hdl.handle.net/20.500.14352/93416 | |
dc.issue.number | 32 | |
dc.journal.title | THE JOURNAL OF BIOLOGICAL CHEMISTRY | |
dc.language.iso | eng | |
dc.page.final | 21972 | |
dc.page.initial | 21960 | |
dc.publisher | Elsevier | |
dc.rights | Attribution 4.0 International | en |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject.cdu | 577.1 | |
dc.subject.ucm | Ciencias Biomédicas | |
dc.subject.unesco | 24 Ciencias de la Vida | |
dc.title | Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling | |
dc.type | journal article | |
dc.type.hasVersion | AM | |
dc.volume.number | 289 | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 4603fb50-fc50-4d17-a7fb-dc93ee96609c | |
relation.isAuthorOfPublication | 62c6bec3-746a-4ca3-ba9b-0dd990ed9528 | |
relation.isAuthorOfPublication | a397c938-999a-4def-a947-7f49b94dceb0 | |
relation.isAuthorOfPublication | db8f53b8-3d54-4c2f-a483-c307151c09df | |
relation.isAuthorOfPublication | c59b144b-f9f2-402e-aba1-5d4c1881eb75 | |
relation.isAuthorOfPublication.latestForDiscovery | 4603fb50-fc50-4d17-a7fb-dc93ee96609c |
Download
Original bundle
1 - 1 of 1
Loading...
- Name:
- Publicación 8. Moreno et al 2014.pdf
- Size:
- 4.39 MB
- Format:
- Adobe Portable Document Format